Understanding Squamous Cell Lung Cancer and Common Treatment Paths

Squamous cell carcinoma is a form of non-small cell lung cancer that develops in the flat cells lining the airways. It can range from localized disease to cancer that has spread throughout the body. Treatment is based on stage, overall health and goals of care, and may involve surgery, radiation, systemic therapy or a combination of approaches. Understanding the reasoning behind each treatment can help guide conversations with your oncologist.

Diagnosis

Diagnosis usually involves imaging tests, a biopsy and staging evaluations to understand how far the cancer has progressed. CT scans, PET scans and MRIs help locate the tumor and identify spread. A biopsy confirms the cancer type. Staging combines all results to determine the best treatment path.

Treatment Options by Stage

What Does Stage 1 Squamous Cell Carcinoma Mean?

At stage 1, the cancer is confined to the lung and has not reached the lymph nodes. Treatment aims for cure, and most patients are eligible for approaches that directly remove or eliminate the tumor.

Frontline

• Surgery to remove the tumor
• Radiation therapy, such as stereotactic body radiation therapy, if surgery is not possible

Second-Line

• Repeat surgery or radiation if the cancer returns
• Systemic therapy considered depending on recurrence pattern

Third-Line and Beyond

• Systemic therapies including immunotherapy or chemotherapy if cancer continues to return or spread

What Should I Expect With Stage 2 Disease?

In stage 2, the cancer is still considered early-stage but may involve nearby lymph nodes. The goal is still cure, and treatment often includes both local and systemic therapy to reduce the risk of recurrence.

Frontline

• Surgery
• Chemotherapy after surgery to lower recurrence risk

Second-Line

• Systemic therapy such as chemotherapy or immunotherapy for recurrence
• Radiation for localized recurrence

Third-Line and Beyond

• Additional systemic options or clinical trials

How Is Stage 3 Squamous Cell Carcinoma Managed?

Stage 3 disease often involves lymph nodes in the center of the chest. Treatment is more complex and often combines multiple therapies aimed at controlling the cancer and possibly achieving long-term remission.

Frontline

• Combined chemotherapy and radiation
• Surgery for select patients
• Immunotherapy after chemoradiation for certain cases

Second-Line

• Immunotherapy or chemotherapy if the cancer grows or returns

Third-Line and Beyond

• Additional systemic therapies or clinical trials

What Happens When Squamous Cell Carcinoma Becomes Metastatic?

At the metastatic stage, the cancer has spread beyond the lung to other organs. Treatment focuses on controlling the cancer, relieving symptoms and supporting quality of life. Many patients receive systemic therapy throughout their care.

Frontline

• Systemic therapy such as chemotherapy, immunotherapy or a combination
• Approach guided by tumor markers and overall health

Second-Line

• Alternative chemotherapy or immunotherapy choices if the cancer grows

Third-Line and Beyond

• Additional systemic therapies, symptom-focused care or clinical trials

Potential Side Effects

Side effects vary with the treatment used. Surgery can cause pain, fatigue or breathing changes. Radiation may lead to skin irritation, fatigue or lung inflammation. Chemotherapy commonly causes nausea, fatigue, hair loss and low blood counts. Immunotherapy can result in immune-related inflammation in organs such as the lungs or liver. Your care team can help prevent or manage side effects, so communication is key.

Conclusion

Learning about squamous cell carcinoma and its treatment options can help you participate actively in your care. Your oncology team can explain each step, discuss treatment goals and help manage symptoms or side effects. Staying informed and asking questions can support you throughout your cancer journey.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.